Sharon Yost
Allergy & Immunology · New York, NYNPI 1306869086
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Sanofi at 26.2% of the total. Reporting peaked in 2022 at $1,349 and has fallen 55.8% since, to $597 in 2025. That places this record below the midpoint for allergy & immunology clinicians in NY, where the typical reported total is $2,174.
Across 119 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$731
- GSK$277
- Regeneron Healthcare Solutions, Inc.$243
- Kaleo, Inc.$208
- Genentech USA, Inc.$197
- AstraZeneca$158
- plus $979 from 15 others
What the payments were for
- Food & beverage$2,793100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 22 | $731 |
| GSK | 21 | $277 |
| Regeneron Healthcare Solutions, Inc. | 8 | $243 |
| Kaleo, Inc. | 9 | $208 |
| Genentech USA, Inc. | 12 | $197 |
| AstraZeneca | 8 | $158 |
| CSL Behring | 6 | $153 |
| Aimmune Therapeutics, Inc. | 7 | $134 |
| Shire North American Group Inc | 1 | $124 |
| Amgen | 5 | $121 |
| Novartis | 5 | $102 |
| Incyte Corporation | 1 | $67 |
| Alk-abello, Inc | 3 | $58 |
| Hikma Pharmaceuticals USA | 2 | $43 |
| Biocryst US Sales Co., LLC | 1 | $36 |
| Pfizer | 1 | $35 |
| Optinose US, Inc. | 2 | $32 |
| Grifols USA, LLC | 2 | $29 |
| Octapharma USA, Inc. | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,793 in reported general payments places this provider in the 50th percentile of 320 allergy & immunology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levocetirizine Dihydrochloride | 21 | $218 |
| Montelukast Sodium | 15 | $77 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in New York
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$946K
- Richard InselNew York$269K
- Purvi ParikhNew York$183K
- Arthur LubitzNew York$165K
- Ama AlexisNew York$120K
- Boyan HadjievNew York$97K
- Charlotte Cunningham-RundlesNew York$95K
- Paula BusseNew York$95K
- Hale YarmohammadiNew York$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.